OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+7.31%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.29%
AUM
$128M
AUM Growth
+$128M
(+11%)
Cap. Flow
+$11.6M
Cap. Flow
% of AUM
9.03%
Top 10 Holdings %
Top 10 Hldgs %
63.26%
Holding
34
New
7
Increased
9
Reduced
11
Closed
4
Top Buys
| 1 |
Harrow
HROW
|
$3.73M |
| 2 |
Prothena Corp
PRTA
|
$3.19M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
$2.26M |
| 4 |
Codexis
CDXS
|
$2.03M |
| 5 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$1.92M |
Top Sells
| 1 |
MZOR
Mazor Robotics Ltd.
MZOR
|
$2.11M |
| 2 |
Travere Therapeutics
TVTX
|
$1.95M |
| 3 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
$1.76M |
| 4 |
PCYC
PHARMACYCLICS INC
PCYC
|
$1.76M |
| 5 |
Karyopharm Therapeutics
KPTI
|
$1.4M |
Sector Composition
| 1 | Healthcare | 76.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMRX
1
DELISTED
Chimerix, Inc.
CMRX
| $20.9M | 16.25% | 755,000 -35,000 | -4% | -$967K |
|
|
PCYC
2
DELISTED
PHARMACYCLICS INC
PCYC
| $9.98M | 7.78% | 85,000 -15,000 | -15% | -$1.76M |
|
|
3
Travere Therapeutics
TVTX
$1.56B
| $9.02M | 7.03% | 1,000,000 -216,400 | -18% | -$1.95M |
|
|
ARIA
4
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $8.1M | 6.31% | 1,500,000 -160,000 | -10% | -$864K |
|
5
Agios Pharmaceuticals
AGIO
$2.19B
| $6.96M | 5.43% | 113,500 -1,500 | -1% | -$92K |
|
|
CLVS
6
DELISTED
Clovis Oncology, Inc.
CLVS
| $6.21M | 4.84% | 140,000 +10,000 | +8% | +$444K |
|
|
CEMP
7
DELISTED
Cempra, Inc.
CEMP
| $5.53M | 4.31% | 504,800 | – | – |
|
|
GNMK
8
DELISTED
GenMark Diagnostics, Inc
GNMK
| $4.93M | 3.85% | 550,000 +50,000 | +10% | +$449K |
|
|
9
Ultragenyx Pharmaceutical
RARE
$2.89B
| $4.81M | 3.75% | 85,000 +40,000 | +89% | +$2.26M |
|
|
INSY
10
DELISTED
Insys Therapeutics, Inc.
INSY
| $4.75M | 3.7% | 122,500 +36,700 | +43% | +$1.42M |
|
11
InspireMD
NSPR
$102M
| $4.59M | 3.58% | 2,088,500 -91,500 | -4% | -$201K |
|
|
12
Codexis
CDXS
$246M
| $3.94M | 3.07% | 1,690,000 +870,000 | +106% | +$2.03M |
|
|
BIND
13
DELISTED
BIND THERAPEUTICS INC
BIND
| $3.87M | 3.01% | 450,000 -42,000 | -9% | -$361K |
|
|
14
Harrow
HROW
$1.44B
| $3.73M | 2.91% | +502,500 | New | +$3.73M |
|
|
15
Prothena Corp
PRTA
$441M
| $3.48M | 2.71% | 157,000 +143,896 | +1,098% | +$3.19M |
|
|
TTPH
16
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $3.39M | 2.64% | 169,700 | – | – |
|
17
Catalyst Pharmaceutical
CPRX
$2.52B
| $3.24M | 2.52% | 975,000 -403,584 | -29% | -$1.34M |
|
|
CSII
18
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.95M | 2.3% | 125,000 -10,000 | -7% | -$236K |
|
19
Alnylam Pharmaceuticals
ALNY
$58.5B
| $2.27M | 1.77% | 29,100 +21,900 | +304% | +$1.71M |
|
|
CELGZ
20
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
| $2.24M | 1.74% | 660,000 | – | – |
|
|
AEGR
21
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $1.92M | 1.5% | +57,500 | New | +$1.92M |
|
|
AXDX
22
DELISTED
Accelerate Diagnostics
AXDX
| $1.92M | 1.49% | +89,200 | New | +$1.92M |
|
|
DRNA
23
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.71M | 1.33% | +134,500 | New | +$1.71M |
|
24
Standard BioTools
LAB
$481M
| $1.64M | 1.28% | +67,000 | New | +$1.64M |
|
25
Geron
GERN
$893M
| $1.64M | 1.28% | +820,000 | New | +$1.64M |
|